Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Endo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Endo's 2013 CNS (central nervous system) sales performance.

Endo Health Solutions

Valeant raises offer for Salix; rival Endo bows out

Valeant raises offer for Salix; rival Endo bows out Has increased bid to $173 per share in cash.  . Valeant has raised its offer for specialty pharma manufacturer Salix after its earlier bid was trumped by Ireland-based Endo. ... In a statement, Endo said it will “continue to be disciplined in our

Endo tries to ride out Valeant with $15.7bn bid for Salix

Endo tries to ride out Valeant with $15.7bn bid for Salix Ireland-based Endo focuses mainly on pain-killing medicines but wants to expand its focus into other specialty pharmaceutical sectors. . ... For Valeant, Endo's intervention comes at a particularly inopportune moment, just as it is proceeding with a

Positive data in Saxenda diabetes prevention study

Positive data in Saxenda diabetes prevention study The results were presented at the annual meeting of the Endocrine Society (ENDO) in San Diego.

Valeant swoops on Salix with $10bn takeover deal

Valeant swoops on Salix with $10bn takeover deal The $158-per-share deal comes after Valeant was reported to be vying against rival Shire to arrange a takeover of Salix, with additional reports linking Endo Pharmaceuticals with the company. .

FlowMetric Diagnostics names president

FlowMetric Diagnostics names president patients.”. Williams has held a variety of commercial leadership roles at Merck and Endo Pharmaceuticals and also has expertise in marketing, sales and reimbursement.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics